Sweat Gland Neoplasms

New abnormal growth of tissue in the SWEAT GLANDS.

Also Known As:

Neoplasms, Sweat Gland; Neoplasm, Sweat Gland; Sweat Gland Neoplasm

Networked: 11 relevant articles (0 outcomes, 2 trials/studies)

Disease Context: Research Results

Neoplasms: 1324753
- Neoplasms by Site: 4
  - Skin Neoplasms: 8909
    - Sweat Gland Neoplasms: 11
Skin and Connective Tissue Diseases
- Skin Diseases: 13127
  - Skin Neoplasms: 8909
    - Sweat Gland Neoplasms: 11
  - Sweat Gland Diseases
    - Sweat Gland Neoplasms: 11

Related Diseases

1.	Neoplasms (Cancer)
2.	Neoplasm Metastasis (Metastasis)
3.	Carcinoma (Carcinomatosis)
4.	Acrospiroma
5.	Breast Neoplasms (Breast Cancer)

Experts

1.	Brenn, Thomas: 1 article (01/2020)
2.	González-Guerra, Elena: 1 article (07/2012)
3.	Kutzner, Heinz: 1 article (07/2012)
4.	Requena, Luis: 1 article (07/2012)
5.	Rutten, Arno: 1 article (07/2012)
6.	Chivukula, Mamatha: 1 article (08/2011)
7.	Dabbs, David J: 1 article (08/2011)
8.	Jukic, Drazen: 1 article (08/2011)
9.	Rollins-Raval, Marian: 1 article (08/2011)
10.	Tseng, George C: 1 article (08/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Sweat Gland Neoplasms:

1.	Glycoproteins (Glycoprotein)IBA 02/01/1996 - "The aim of the study was to evaluate the distribution of the respective glycoproteins of the CEA family in sweat gland neoplasms, as compared to normal sweat glands. "
2.	dibenzthione (D 47)IBA 01/01/1985 - "From this study it becomes clear that D 47 represents an immunohistologic marker of eccrine-secretory differentiation and that it can be applied in the investigation of the differentiation and of the differential diagnosis of sweat-gland neoplasms."
3.	Proteins (Proteins, Gene)FDA Link 12/01/1996 - "The overall cellular distribution of CEA and EMA was highly preserved in benign sweat gland neoplasms whereas malignant neoplasms were characterized by loss of protein targeting and cellular polarity. " 08/01/2011 - "Twelve cases of ductal CMBCs (11 not otherwise specified type, and 1 basal phenotype), 11 cases of SGCs (5 eccrine carcinomas, 3 porocarcinomas, and 3 microcystic adnexal carcinomas), 2 benign sweat gland neoplasm cases, and 2 primary breast cancer cases were retrieved and analyzed with the following IHC panel: mammaglobin, gross cystic disease fluid protein (GCDFP) 15, p63, basal cytokeratins (CK5, CK14, and CK17), androgen receptor, and PAX5. "
4.	AntibodiesIBA 02/01/1996 - "A panel of mono-specific antibodies was applied to a total of 83 samples of hyperplastic and cystic alterations of sweat glands, sweat gland neoplasms, and cutaneous metastases of different origin. " 12/01/1996 - "Therefore, normal human skin, 19 cases of various sweat gland neoplasms, Paget's disease, and cutaneous metastases of visceral carcinomas were stained with well-defined antibodies using a postembedding immunogold technique. "
5.	Calbindin 2IBA 07/01/2012 - "Calretinin immunoreactivity supports eccrine differentiation in some sweat gland neoplasms, and it is also useful in identifying neoplasms with ductal sebaceous differentiation."
6.	Keratin-14 (Keratin 14)IBA 01/01/2002 - "To elucidate the roles of CD34-positive stromal cells and alpha-smooth muscle actin-positive stromal cells at the tumor border of skin sweat gland neoplasms, we examined expression of stromal cell markers in the tumor capsule of 19 skin sweat gland neoplasms (16 mixed tumors of the skin and three nodular hidradenomas) using monoclonal antibodies to CD34, CD31, cytokeratin 14 (CK14), alpha-smooth muscle actin (ASMA) and high molecular weight caldesmon (HCD). "
7.	Messenger RNA (mRNA)IBA 11/01/2023 - "This tumor harbored human papillomavirus-18 DNA and mRNA, raising the question of the role of the oncogenic virus in sweat gland neoplasms of the vulva."
8.	Androgen Receptors (Androgen Receptor)IBA 08/01/2011 - "Twelve cases of ductal CMBCs (11 not otherwise specified type, and 1 basal phenotype), 11 cases of SGCs (5 eccrine carcinomas, 3 porocarcinomas, and 3 microcystic adnexal carcinomas), 2 benign sweat gland neoplasm cases, and 2 primary breast cancer cases were retrieved and analyzed with the following IHC panel: mammaglobin, gross cystic disease fluid protein (GCDFP) 15, p63, basal cytokeratins (CK5, CK14, and CK17), androgen receptor, and PAX5. "
9.	S100 Proteins (S 100 Protein)IBA 07/01/1984 - "[Immunohistochemical localization of S-100 protein in sweat gland neoplasms]."
10.	Ferritins (Ferritin)IBA 02/01/1990 - "Immunohistochemical demonstration of ferritin in sweat gland and sweat gland neoplasms." 02/01/1990 - "Diffuse ferritin staining of certain sweat gland neoplasms may be an indication of biologic activity and potential aggressivity of these neoplasms."

Therapies and Procedures

1.	Radiotherapy 04/15/1990 - "The role of radiotherapy in the treatment of malignant sweat gland neoplasms."